Chemosensitivity of BRCA1-Mutated Ovarian Cancer Cells and Established Cytotoxic Agents. [electronic resource]
Producer: 20180208Description: 1571-1578 p. digitalISSN:- 1525-1438
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- BRCA1 Protein -- genetics
- Cell Line, Tumor
- Cisplatin -- administration & dosage
- Cystadenocarcinoma, Serous -- drug therapy
- Drug Resistance, Neoplasm
- Drug Synergism
- Female
- Genes, BRCA1
- Germ-Line Mutation
- Humans
- Immunohistochemistry
- Lactones -- administration & dosage
- Ovarian Neoplasms -- drug therapy
- Phthalazines -- administration & dosage
- Piperazines -- administration & dosage
- Sesquiterpenes -- administration & dosage
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.